TLR4 and breast carcinoma: On the contrary, other studies pointed out that e.g., silencing of TLR4 increased tumor progression and lung metastases in a murine model of breast cancer [54] and that TLR9 agonists could induce apoptosis in A20 lymphoma cells [55] and neuroblastoma cells [56].